The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,920,194 in first-year total cost, median $573,025.
Most frequent study sections
- Clinical, Treatment and Health Services Research Study Section[AA-3]4
- Clinical, Treatment and Health Services Research Study Section[AA-3 (03)]1
Most frequent institutions
- MEDICAL UNIVERSITY OF SOUTH CAROLINA1
- UNIVERSITY OF KENTUCKY1
- UNIVERSITY OF MARYLAND BALTIMORE1
- UT SOUTHWESTERN MEDICAL CENTER1
- YALE UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Neuroactive Steroid Potentiation to Decrease Alcohol Craving, Normalize HPA axis function and Prevent Alcohol Relapse1R01AA026514-01A1 | SINHA, RAJITA | YALE UNIVERSITY, CT | $680,592 | AA |
| 2018 | A Novel Drug Combination for Alcohol-Use Disorders: A Human Laboratory Study1R01AA026255-01A1 | RUSH, CRAIG R | UNIVERSITY OF KENTUCKY, KY | $609,013 | AA |
| 2018 | Genomic Predictors of Placebo response in Phase II AUD trials1R01AA026291-01 | JOHNSON, BANKOLE ASENEVIRATNE, CHAMINDI | UNIVERSITY OF MARYLAND BALTIMORE, MD | $514,295 | AA |
| 2016 | A Randomized Controlled Trial of N-Acetylcysteine for Alcohol Use Disorder and Comorbid PTSD1R01AA025086-01 | BACK, SUDIE EGRAY, KEVIN M | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $573,025 | AA |
| 2016 | Dopamine-2 Receptor Partial Agonist for Bipolar Disorder and Alcohol Use Disorder1R01AA024420-01A1 | BROWN, E SHERWOOD | UT SOUTHWESTERN MEDICAL CENTER, TX | $543,269 | AA |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.